Submit your email to push it up the queue
Corindus Vascular Robotics, Inc., a leader in the field of robotic-assisted vascular interventions, is headquartered in the United States. Founded in 2004, the company has made significant strides in advancing the capabilities of minimally invasive procedures, particularly in the treatment of coronary artery disease. Corindus is renowned for its innovative robotic systems, such as the CorPath GRX, which enhances precision and control during complex vascular procedures. This unique technology not only improves patient outcomes but also optimises workflow for healthcare professionals. With a strong market position, Corindus has established itself as a pioneer in the medical robotics industry, contributing to the evolution of interventional cardiology. The company continues to focus on expanding its operational reach and enhancing its product offerings to meet the growing demands of healthcare providers worldwide.
How does Corindus Vascular Robotics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Corindus Vascular Robotics, Inc.'s score of 86 is higher than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Corindus Vascular Robotics, Inc., headquartered in the US, currently does not have specific carbon emissions data available for reporting. As a current subsidiary of Siemens Healthineers AG, any climate commitments or emissions data would be inherited from this parent organisation. While there are no documented reduction targets or specific emissions figures, Corindus is aligned with the sustainability initiatives of Siemens Healthineers, which may include industry-standard climate commitments. However, without explicit data or targets from Corindus itself, it is challenging to provide a detailed overview of their carbon footprint or reduction strategies. As the company continues to operate under the umbrella of Siemens Healthineers, it is expected to adhere to the broader climate goals set by the parent company, which may include commitments to reduce emissions and enhance sustainability practices across its operations.
Access structured emissions data, company-specific emission factors, and source documents
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|
Scope 1 | 138,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 2 | 60,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 3 | 2,907,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Corindus Vascular Robotics, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.